WINNIPEG, MB, Aug. 20, 2020 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a pharmaceutical company, today announced the termination of the marketing and ...
WINNIPEG, MB / ACCESS Newswire / April 23, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and ...
INVESTS US$10.0 MILLION IN SENSIBLE MEDICAL WINNIPEG, Jan. 28, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is ...
WINNIPEG, MB / ACCESS Newswire / June 17, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals ...
WINNIPEG, MB, Jan. 7, 2021 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a cardiovascular pharmaceutical company, today announced that through its Barbados ...
WINNIPEG, MANITOBA--(Marketwire - Sept. 26, 2012) - Medicure Inc. ("Medicure" or the "Company") (MPH.V)(MCUJ), is pleased to announce the development of a transdermal delivery formulation of its lead ...
Q4 2025 Earnings Call April 27, 2026 8:30 AM EDTCompany ParticipantsAlbert Friesen - Founder, CEO & Chairman of the ...
WINNIPEG, MB / ACCESS Newswire / April 17, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and h ...
WINNIPEG, MANITOBA--(Marketwire - Sep 21, 2012) - Medicure Inc. ("Medicure" or the "Company") (TSX VENTURE:MPH)(MCUJ), a specialty pharmaceutical company, announced today that its Board of Directors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results